ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Centers May Become More specialized, Klausner Tells AACI

April 26, 1996

In Brief: Earl Pollack To Retire As Head Of Seer Program; Nursing Foundation, Lederle Offer Scholarships

December 7, 1984

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

WHT Participants Get “Phase Out” Help

March 11, 1988

Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report

July 30, 1999

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986